Bilgi Düzensizlikleri ve İnfodemi İçin Bir Örnek: Aşı Karşıtlığı

Even though “anti-vaccination” views are not new, the abundance of misinformation regarding the vaccines in the digital environment erodes the trust to vaccines even further. Vaccines have been one of the most effective measures against infections diseases, they prevented many deaths and eradicated deadly diseases in some areas. Most of the hesitancy against vaccines have no scientific background whatsoever, and these unfounded misinformative claims contribute to vaccine hesitancy further for individual and societies. Some of the main factors that leads to anti-vaccination stance or vaccine hesitancy are loss of collective memory regarding the dangers of infectious diseases, concerns around safety and efficiency of vaccines, naturalistic fallacy, mistrust in science and scientific process and conspiracy theories. Prompting questioning the logic behind the conspiracy theories might be effective against vaccine disinformation.Günümüzdeki “aşı karşıtlığı” yeni olmamakla birlikte, özellikle dijital ortamda yayılan yanlış bilgiler önemli bir güven sorunu yaratmaktadır. Aşıların enfeksiyon hastalıkları ile mücadelede en etkili koruma yöntemi olduğunu vurgulayabiliriz; birçok ölümü engellediği gibi kimi coğrafyalarda ortadan kaldırılan hastalıklar da olmuştur. Aşılar konusunda olumsuzluklar büyük oradan bilimsel verilere dayanmamakta ve bu haberler bireyleri ve toplumları aşıdan soğutma riskini yaratmaktadır. Aşı karşıtlığını körükleyen etmenler arasında toplumsal hafıza zayıflığı, ebeveynlerin güvenlik ve etkinlik endişeleri, doğallık arayışı, bilime ve bilim süreçlerine güvensizlik ve komplo kuramları yer alır. İnanılan komplo kuramlarının mantığına ilişki soruların yöneltilmesi bu inançlarla mücadelede etkili olabilir

Mutations in Influenza A Virus (H5N1) and Possible Limited Spread, Turkey, 2006

We report mutations in influenza A virus (H5N1) strains associated with 2 outbreaks in Turkey. Four novel amino acid changes (Q447L, N556K, and R46K in RNA polymerase and S133A in hemagglutinin) were detected in virus isolates from 2 siblings who died

Trends in prevalence of hepatitis B virus infection among Albanian blood donors, 1999-2009

<p>Abstract</p> <p>Background</p> <p>Hepatitis B virus (HBV) was among the first virus known to be transmitted by blood and blood productions. The objective of this study is to determine the trend of hepatitis B virus in blood donors.</p> <p>Materials and methods</p> <p>In this study 79274 blood donors were retrospectively evaluated for HBsAg. The donors were selected using personal questionnaire, physical examination and testing blood before donation. Blood banks records are used as source of information. The blood donors samples were analyzed for the presence of hepatitis B surface antigen (HBsAg) by commercial available kits ELISA method, third generation (from Abbott laboratory, Germany). A sample was considered as HBsAg positive when found twice repeatedly reactive. Reactive samples were not confirmed with addition tests.</p> <p>Results</p> <p>In the evaluation data, we found out that from 79274 of the total healthy blood donors, 15983 were voluntary donors, 52876 were family replacement donors and 10424 commercial blood donors. The prevalence of HBsAg in blood donors was 7.9%. It was increased steadily from 5.9% in 1999 to 9.1% in 2006 and decreased in 7.9% in 2009. According to blood donors status the HBsAg prevalence was 10.5% in commercial blood donors, 8.1% in voluntary donors and 8.6% in family replacement donors. The prevalence of anti-HBc in blood donors was 59.1%.</p> <p>Conclusion</p> <p>The prevalence of HBsAg was lower in voluntary non remunerate blood donors than commercial donors and family replacement blood donors. In FDs the prevalence was higher than VDs but lower than CDs. So, it is important to encourage the voluntary blood donors to become regularly blood donors.</p

The epidemiology of pandemic influenza A (H1N1) 2009

2009 is marked by the public health problems caused by "pandemic H1N1 virus". This virus with new antigenic properties, against which no protection exist in human populations, has spread over the continents in a very short period of time causing WHO to raise the pandemic level to "level 6" on June 11, 2009. This report covers the virological properties of the pandemic A ( H1N1) 2009 virus, and the epidemiological properties of the 2009 pandemic. (Turk Arch Ped 2010; 45: 80(th) Year: 25-30